Summary
Recurrent pericarditis is a rare disease in childhood. Nevertheless, it may represent a challenge to the clinician due to its resistance to anti-inflammatory treatment. The initial etiology often remains unclear; specific laboratory parameters predicting the frequency or severity of the recurrences are lacking. We report on four patients with recurrent pericarditis in whom antimyolemmal antibodies (AMLAs) were detected. A prolonged persistence of IgM-type AMLAs was found in three patients: two of them presented with acute inflammation as the initial event and one with 48 recurrences during 5.5 years. The fourth patient showed a fast conversion from IgM to IgG-type AMLAs after a less acute initial presentation and showed 4 mild recurrences during the 48-month follow-up.
Conclusion
We were able to detect AMLAs in four children with recurrent pericarditis. This finding may be attributed to an auto-immunological disease following a first, acute event. We propose the detection of AMLAs in all children with unexplained recurrent pericarditis. Pediatric patients with a persistence of IgM-type AMLAs may face frequent recurrences and should be monitored therefore more closely. In addition, medical treatment may be changed in these patients with a slower tapering of the dosage of steroidal and non-steroidal antiinflammatory drugs.
Similar content being viewed by others
References
Allen HD, Gutgesell HP, Clark EB, Driscoll DJ (2001) Moss and Adams' heart diseases in infants, children, and adolescents, 6th edn. Lippincott Williams & Wilkins, Philadelphia
Fowler NO, Harbin AD III (1986) Recurrent acute pericarditis: follow up study of 31 patients. J Am Coll Cardiol 7:300–305
Godeau P, Derrida J-P, Bletry O, Herreman G (1975) Péricardites aigus récidivantes et cortico-dépendance. Sem Hp Paris 51:2393–2401
Herzum M, Ruppert V, Küytz B, Jomaa H, Nakamura I, Maisch B (1994) Coxsackie B3 Infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol 26:907–913
Kabukcu M, Demircioglu F, Yanik E, Basarici I, Ersel F (2004) Pericardial tamponade and large pericardial effusions: causal factors and efficacy of percutaneous drainage in 50 patients. Tex Heart Inst J 31:398–403
Maisch B, Deeg P, Libau G, Kochsiek K (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in patients with primary and secondary heart muscle diseases. Am Heart J 106:329–337
Maisch B (1984) Secondary immunopathogenesis of cardiac diseases. Fortschr Med 18:516–520
Maisch B (1985) Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis. Heart Vessels (Suppl 1):209–217
Maisch B, Outzen H, Roth D, Hiby A, Herzum M, Hengstenberg C, Hufnagel G, Schönian U, Kochsiek K (1991) Prognostic determinants in conventionally treated myocarditis and perimyocarditis – focus on antimyolemmal antibodies. Eur H Jour 12 (Suppl):81–87
Maisch B, Drude L, Hengstenberg C, Hufnagel G, Schönian U, Schwab D (1992) Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis. Postgrad Med J 68(Suppl):11–16
Maisch B, Bauer E, Cirsi M, Kochsiek K (1993) Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. Circulation 87(Suppl):49–65
Maisch B, Ristic AD, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23:1503–1508
Maisch B, Ristic AD, Hufnagel G, Pankuweit S (2002) Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 11:112–122
Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004) Guidelines on the diagnosis and management of pericardial disease – executive summary. The Task Force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur H Jour 25:587–610
Marcolongo R, Russo R, Laveder F Noventa F, Agostani C (1995) Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol 26:1276–1279
Raatikka M, Pelkonen PM, Karjalainen J, Jokinen EV (2003) Recurrent pericarditis in children and adolescents. J Am Coll Cardiol 42:759–764
Robinson J, Brigden W (1968) Recurrent pericarditis BMJ 2:272–275
Sentongo TAS, Piccoli DA (1998) Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature. J Pediatr Gastroenterol Nutr 27:344–347
Yazigi A, Abou-Charaf LC (1998) Colchicine for recurrent pericarditis in children. Acta Paediatr 87:603–604
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dalla Pozza, R., Hartl, D., Bechtold, S. et al. Recurrent pericarditis in children: elevated cardiac autoantibodies. Clin Res Cardiol 96, 168–175 (2007). https://doi.org/10.1007/s00392-007-0471-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-007-0471-6